Skip to main content

Table 3 Financial indicators and number of Pharma donors from annual reports and websites, analysed by disease.

From: Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey

Disease group & no. of patient organisation websites Annual report available from website Median Net assets ($000,000s) [n]b Median annual revenuec ($000,000s) [n] Donationsd received as proportion of revenue; median [n] Corporate donationse as prop. of revenue; median [n] Median no. (range) Pharma sponsors (Website)f Median no. (range) Pharma sponsors (Ann. report)
Arthritis (5) 4 5.2 [4] 5.3 [3] 0.52 [3] 0.07 [1] 8.5 (5–10) 3.5 (0–19)
Asthma (7) 4 4.7 [4] 5.0 [4] 0.65 [4] 0.32 [2] 4 (0–14) 6.5 (0–9)
Cancer (5) 4 630.0 [3] 260.0 [4] 0.58 [3] 0.05 [1] 0 (0–2) 3 (0–8)
Cystic fibrosis (5) 4 1.0 [3] 6.3 [3] 0.55 [3] - 0 (0–2) 2.5 (0–10)
Diabetes (8) 4 20.7 [3] 98.0 [3] 0.77 [3] - 2 (0–15) 14.5 (1–29)
Depression (9) 1 1.1 [1] 3.0 [1] 0.92 [1] - 0 11
Epilepsy (8) 4 1.9 [3] 4.5 [4] 0.58 [4] - 0.5 (0–6) 3.5 (0–8)
Heart disease (8) 5 47.0 [3] 140.0 [4] 0.65 [4] 0.65 [1] 2 (0–7) 1 (0–38)
Osteoporosis (6) 4 7.2 [3] 4.9 [4] 0.66 [4] 0.38 [1] 3.5 (0–21) 11 (6–13)
Parkinson's (7) 3 22.0 [2] 9.5 [3] 0.78 [3] 0.07 [1] 1 (0–11) 7 (0–17)
Total (n = 69) 37 13.0 [29] 11.0 [33] 0.68 [32] 0.11 [7] 1 (0–21) 6 (0–38)
  1. Notes:
  2. aSee Methods for description of data standardisation across currency and year.
  3. bNot all annual reports contained the necessary information; n = number of valid data entries.
  4. cTotal income over the year of the annual report from all sources (excluding costs of fundraising activities).
  5. dDonations includes legacies/bequests and membership dues, but excludes donated services and materials and special events.
  6. eCorporate donations generally exclude donated services and materials, sponsored fellowships and research awards.
  7. fOnly those websites having an annual report for comparison